FDA approves new treatment for adults with partial-onset seizures
FDA approves new treatment for adults with partial-onset seizures
MHRA drug alert: recalls for 13 over-the-counter Ranitidine medicines
MHRA drug alert: recalls for 13 over-the-counter Ranitidine medicines
CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib
CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib
Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients...
Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate...
Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate for Alcohol Use Disorder
